Navigation Links
Healthcare Travel Exhibition & Congress Predicts Worldwide Healthcare Travel Revenue to Hit US$100 Billion by 2012
Date:6/28/2009

SINGAPORE, June 29 /PRNewswire-Asia/ -- Rising healthcare standards together with the growing demand for more affordable treatment will keep the Asian market for medical tourism buoyant, according to experts speaking at the Healthcare Travel Exhibition & Congress today at Fairmont Hotel, Singapore. Worldwide gross medical tourism revenue is projected to grow from US$56 billion to reach US$100 billion by 2012, with Asia as a major driver of this growth.

"Buoyed by the success stories of earlier waves of medical tourists, consumers, insurance companies as well businesses fully recognise the reliability and affordability of going overseas for medical procedures. Patients who choose to undergo treatments in Asia can pay just 10% of the cost of comparable treatment conducted in developed countries like the United States or United Kingdom. This differential cost, coupled with today's sophisticated travel industry, provides an excellent catalyst to the growth of medical tourism," said Mr. Andrew Keable, Divisional Director, Informa Life Sciences.

Asia is well-placed to grow in medical tourism as healthcare standards and technology adoption continue to improve. Hospitals in Korea, Malaysia, Thailand, India and Singapore have made it a point to implement state-of-the- art medical technologies to improve patient care.

Healthcare Travel Exhibition & Congress 2009 is Asia's premier event focusing on two of the world's largest industries: healthcare and tourism. The event brings together professionals, government officials and decision makers from the healthcare and travel industries, giving them the opportunity to network and share best practices, insights and knowledge to further develop Asia's thriving healthcare travel market.

Leading edge technology is on display at the exhibition portion of the event, where close to 30 exhibitors including leading medical suppliers, healthcare travel facilitators, medical spas and hospitals are showcasing their innovations and services. Governments too have begun to recognise the economic potential and are responding by actively participating in the promotion of their respective countries as attractive healthcare destinations.

    The conference themes at the Congress portion of the event include:

    -- 29th - 30th June: The global healthcare travel outlook, new challenges
       and opportunities in healthcare travel, payment and accreditation
       standards
    -- 29th - 30th June: Healthcare insurance trends in Asia, best practices,
       and emerging partnerships
    -- 29th June: Travel Business Day co-organised with Pacific Asia Travel
       Association (PATA), covering medical tourist requirements, business
       cases, misconceptions and the healthcare travel ecosystem
    -- 1 July: Minimizing legal liabilities in global healthcare travel
    -- 1 July: Health insurance risk management for new markets

"We have an impressive line-up of industry leaders and luminaries who will be sharing key topics specifically designed for the medical tourism industry. The exclusive congress segment ensures the unique position of Healthcare Travel Exhibition & Congress as Asia's leading medical tourism event", said Ms. Rebecca Wolfe, Divisional Director, Informa Life Sciences.

Healthcare Travel Exhibition & Congress is sponsored by Singapore Medicine, CKMP-Council for Korea Medicine Overseas Promotion and National Healthcare Group. The event is also supported by International Enterprise Singapore, International Medical Travel Association (IMTA), Life Insurance Association, Pacific Asia Travel Association (PATA), Spa and Wellness Association Singapore, Thai Spa Association, and Spa Association Singapore.

    For more information, please visit
http://www.healthcaretravel-singapore.com

About Informa Life Sciences

Healthcare Travel Exhibition & Congress is part of a global series of life sciences events organized by Informa Life Sciences, the world's leader in providing quality conferences, publications and learning experiences for the life sciences industry. Along with Arab Health, Hospital Build and Aesthetics Asia, Healthcare Travel Exhibition & Congress also takes place annually in Dubai.

Informa Life Sciences leads the market in providing quality, expert-led conferences; delivering the expert knowledge our clients need to excel in their professional roles and guaranteeing a competitive advantage for their organizations. Our diverse portfolio covers the Pharmaceutical (Drug Discovery, Clinical Development, Regulatory Affairs, Biopharmaceutical, Generics and Business Strategy), Medical Devices and Diagnostics, Fine Chemicals and Agrochemicals and Veterinary Medicine arenas.

    For media enquiries, please contact:

     Samuel Chua/Florence Fang
     Flame Communications
     Tel:   +65-6259-3193
     Email: samuel@flamecomms.com/florence@flamecomms.com

     Yvonne Lim
     Senior Marketing Manager
     Asia Pacific Life Sciences Division
     IIR Exhibitions Pte Ltd
     Tel:   +65-6517-3027
     Email: yvonne.lim@iirx.com.sg

'/>"/>
SOURCE Informa Life Sciences
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. WellNet Introduces Healthcare Performance Management on Capitol Hill
2. Five Genesis HealthCare Centers To Be Awarded Prestigious National Award
3. Healthcare Staffing Company Medical Solutions Named Among "2009 Best Places to Work in Omaha"
4. Federal Trade Commission Reports: Authorized Generics, During the 180-day Exclusivity Period, Benefit Consumers and the American Healthcare System
5. UnitedHealthcare and Fusion Sleep Announce New Agreement
6. Akerman Senterfitt Announces Expansion of Healthcare Practice
7. Traveling Healthcare Staffing Company, Medical Solutions, Announces a Ttitle change for its Recruiters to Career Consultants
8. Siemens Healthcare Testifies on Healthcare Reform and Building a Healthier America
9. U.S. Womens Chamber of Commerce Advocates Strong Healthcare Reforms in Support of American Values
10. Sharp HealthCare and Anakam(R) Partner to Protect Patients Health Information
11. CED/Zogby Release Survey of Business Perspectives on Healthcare Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... While new U.S. opioid ... physicians are not legally required to follow them. In the absence of federal ... Novus Medical Detox Center , a leading Florida-based drug treatment facility, strongly ...
(Date:5/23/2016)... ... ... the upcoming airing of Innovations with Ed Begley, Jr., ... 4:00pET via Fox Business. , The show will explore ... safely and rapidly develop cures for mosquito-borne, emerging infectious ...
(Date:5/23/2016)... , ... May 23, 2016 ... ... Size for Verification and Validation:, Tools to Safely Speed Your Device to ... http://www.fdanews.com/bestdevicesamplesizevv                  , Today's FDA inspectors focus like lasers on device ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... ... the action analytics leader as Chief Medical Officer. Dr. O’Connor’s deep expertise in ... product development and client services teams who deliver best-in-class solutions and transformative technologies ...
(Date:5/23/2016)... Valley, California (PRWEB) , ... May 23, 2016 ... ... clinical communications and solutions for healthcare providers announced today that AGNITY MobileCare™ Platform ... and health collaboration applications as a part of its M-Health Solution. Tech Mahindra ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... Israel , May 19, 2016 ... the "Company"), an emerging global ophthalmic company focused on ... candidates which address ophthalmic conditions, announced today that it ... Italy ) for the manufacturing, distribution, marketing ... for the treatment of dry eye syndrome (DES) and ...
(Date:5/19/2016)... May 19, 2016 A ... World Biopsy Devices Market Opportunities and Forecasts, 2014 ... market generated $1,621 million in 2015. The MRI-guided ... and is expected to maintain this trend over ... http://photos.prnewswire.com/prnh/20140911/647229 ) , To know ...
(Date:5/19/2016)... BioLineRx Ltd. (NASDAQ/TASE: BLRX) announced ... of multiple cancer and hematological indications, will be presented ... titled " Clinical response in relapsed/refractory AML patients correlates ... a potent CXCR4 antagonist; results of a Phase 2a ... the European Hematology Association 21st Congress, to be held ...
Breaking Medicine Technology: